APA (7th ed.) Citation

Moccia, M., Affinito, G., Marrazzo, G., Ciarambino, T., Di Procolo, P., Confalonieri, L., . . . Palladino, R. (2024). Utilization of Ocrelizumab within Different Treatment Strategies for Multiple Sclerosis: A 5-Year Population-Based Study. Neurology International, 16(2), 394. https://doi.org/10.3390/neurolint16020029

Chicago Style (17th ed.) Citation

Moccia, Marcello, et al. "Utilization of Ocrelizumab Within Different Treatment Strategies for Multiple Sclerosis: A 5-Year Population-Based Study." Neurology International 16, no. 2 (2024): 394. https://doi.org/10.3390/neurolint16020029.

MLA (9th ed.) Citation

Moccia, Marcello, et al. "Utilization of Ocrelizumab Within Different Treatment Strategies for Multiple Sclerosis: A 5-Year Population-Based Study." Neurology International, vol. 16, no. 2, 2024, p. 394, https://doi.org/10.3390/neurolint16020029.